Ovid Therapeutics Valuation Multiples

Ovid Therapeutics Overview

About Ovid Therapeutics

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Founded

2014

HQ

Employees

23

Website

ovidrx.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $5M

Net Income: ($29M)

EV

$379M

Valuation Multiples

Multiples.vc

Start free trial

Ovid Therapeutics Financials

Ovid Therapeutics reported last 12-month revenue of $5M.

In the same LTM period, Ovid Therapeutics generated $5M in gross profit and had net loss of ($29M).

Ovid Therapeutics P&L

In the most recent fiscal year, Ovid Therapeutics reported revenue of $7M and EBITDA of ($42M).

Ovid Therapeutics expects next 12-month revenue of XXX and NTM EBITDA of XXX

Ovid Therapeutics Stock Performance

Ovid Therapeutics has current market cap of $435M, and enterprise value of $379M.

Ovid Therapeutics' stock price is $2.88.

Ovid Therapeutics Valuation Multiples

Ovid Therapeutics trades at 71.0x EV/Revenue multiple, and (9.0x) EV/EBITDA.

Ovid Therapeutics Financial Valuation Multiples

As of April 11, 2026, Ovid Therapeutics has market cap of $435M and EV of $379M.

Equity research analysts estimate Ovid Therapeutics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ovid Therapeutics has a P/E ratio of (14.8x).

Ovid Therapeutics Margins & Growth Rates

Ovid Therapeutics' revenue in the last 12 month declined by (95%).

Ovid Therapeutics' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $2.2M for the same period.

Ovid Therapeutics Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Ovid Therapeutics M&A Activity

Ovid Therapeutics acquired XXX companies to date.

Last acquisition by Ovid Therapeutics was on XXXXXXXX, XXXXX. Ovid Therapeutics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Ovid Therapeutics Investment Activity

Ovid Therapeutics invested in XXX companies to date.

Ovid Therapeutics made its latest investment on XXXXXXXX, XXXXX. Ovid Therapeutics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).